To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products.
To discover, develop and provide innovative products and services that can save and improve lives around the world.
MSD is one of the world's leading research-based biopharmaceutical companies with a history that goes back more than 125 years. We have made it our mission to contribute to improving health around the world. Our company is called MSD (Merck Sharp & Dohme) everywhere except in the USA and Canada, where it is known as Merck & Co., Inc., Kenilworth, NJ, USA.
Main business areas
pharmaceuticals, vaccines, animal health products
Corporate headquarters
Kenilworth, N.J., U.S.A.
140 locations worldwide
Research budget
$ 7.3 billion for research and development (as of 2017)
With a strong focus on innovation and sound science, we research, develop and provide medicines and vaccines.
Learn more
With a strong focus on innovation and sound science, we research, develop and provide medicines and vaccines.
Learn moreAbout 1220 people from more than 25 nationalities are employed at our 4 sites, working in local and international roles.
Learn more
About 1220 people from more than 25 nationalities are employed at our 4 sites, working in local and international roles.
Learn moreOur sites in Belgium & Luxembourg
Learn moreMSD’s Leadership Team in Belgium & Luxembourg
Learn moreOur values and standards represent our corporate character. They guide our decisions and actions and have earned us trust and respect of our colleagues, partners and customers within the health care sector.
Ethics and transparency are cornerstones of MSD's corporate reputation.
Our values and standards are stated in the "MSD Code of Conduct."
As one of the world's leading research-based biopharmaceutical companies, MSD has been pioneering medical progress for more than 125 years. During this time, we have been able to significantly improve treatment of numerous serious and chronic diseases. In the past 50 years alone, MSD has brought 40 new medicines onto the market - many of them representing a new class of active ingredients.
